BDBM156371 US9018371, 12

SMILES OC1CS[C@H]([C@H]1O)n1cnc2c(NCc3cccc(Cl)c3)ncnc12

InChI Key InChIKey=CKXSTCOOOXXOLA-GRLMSTMOSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 156371   

TargetAdenosine receptor A2a(Homo sapiens (Human))
Fm Therapeutics

US Patent
LigandPNGBDBM156371(US9018371, 12)
Affinity DataKi:  1.5nMAssay Description:CHO cells (ATCC No. CCL-61), in which A1 and A3 adenosine receptors were expressed, were cultured in F-12 media (Gibco, U.S.A.) supplemented with 10%...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Fm Therapeutics

US Patent
LigandPNGBDBM156371(US9018371, 12)
Affinity DataKi:  440nMAssay Description:CHO cells (ATCC No. CCL-61), in which A1 and A3 adenosine receptors were expressed, were cultured in F-12 media (Gibco, U.S.A.) supplemented with 10%...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A1(Homo sapiens (Human))
Fm Therapeutics

US Patent
LigandPNGBDBM156371(US9018371, 12)
Affinity DataKi:  860nMAssay Description:CHO cells (ATCC No. CCL-61), in which A1 and A3 adenosine receptors were expressed, were cultured in F-12 media (Gibco, U.S.A.) supplemented with 10%...More data for this Ligand-Target Pair
In DepthDetails US Patent